In the BioHarmony Drug Report Database
Albumin
Optison (albumin human) is a protein pharmaceutical. Albumin human was first approved as Optison on 1997-12-31. Albuked’s patent is valid until 2021-04-20 (FDA).
Trade Name
|
Optison |
|---|---|
Common Name
|
albumin human |
ChEMBL ID
|
CHEMBL1201451 |
Indication
|
|
Drug Class
|
Image (chem structure or protein)
